AMH Is a Good Predictor of Metabolic Risk in Women with PCOS: A Cross-Sectional Study
Objective. The relationship between metabolic risk and ovarian function is ambiguous. This retrospective study analyzed the medical records of 461 PCOS patients collected between January 2019 and June 2020 to investigate the relationship between serum anti-Müllerian hormone (AMH) and parameters of m...
Saved in:
Main Authors: | Miaoxian Ou, Pei Xu, Han Lin, Kaichi Ma, Mingxing Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | International Journal of Endocrinology |
Online Access: | http://dx.doi.org/10.1155/2021/9511772 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Serum Kisspeptin and AMH Levels Are Good References for Precocious Puberty Progression
by: Jiang Xue, et al.
Published: (2020-01-01) -
How Much Does AMH Really Vary in Normal Women?
by: Antonio La Marca, et al.
Published: (2013-01-01) -
Distribution and Related Influencing Factors of AMH Level in Family-Planning Women of Childbearing Age: A Cross-Sectional Study from Beijing, China
by: Song J, et al.
Published: (2025-01-01) -
Whole Exome Sequencing Reveals Rare Variants in Genes Associated with Metabolic Disorders in Women with PCOS
by: Priyal Sharma, et al.
Published: (2023-10-01) -
The Correlation between Hormonal Disturbance in PCOS Women and Serum Level of Kisspeptin
by: Razaw O. Ibrahim, et al.
Published: (2020-01-01)